Showing results (131-140 of 194) with videos related to

Sort By:
Pageof 20
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|July 9, 2008
Further evidence that D90A-SOD1 mutation is recessively inherited in ALS patients in ItalyFrancesca Luisa Conforti, Teresa Sprovieri, Rosalucia Mazzei, et al.
Critical Reviews in Oncology/Hematology|April 11, 2016
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statementMichela Buglione, Roberta Cavagnini, Federico Di Rosario, et al.
Molecular Cancer Therapeutics|October 1, 2010
Specific alterations of microRNA transcriptome and global network structure in colorectal carcinoma after cetuximab treatmentMarco Ragusa, Alessandra Majorana, Luisa Statello, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 10, 2019
Systematic review of photobiomodulation for the management of oral mucositis in cancer patients and clinical practice guidelinesYehuda Zadik, Praveen R Arany, Eduardo Rodrigues Fregnani, et al.
Journal of Molecular Medicine (Berlin, Germany)|June 5, 2012
Specific alterations of the microRNA transcriptome and global network structure in colorectal cancer after treatment with MAPK/ERK inhibitorsMarco Ragusa, Luisa Statello, Marco Maugeri, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 10, 2019
Systematic review of natural and miscellaneous agents for the management of oral mucositis in cancer patients and clinical practice guidelines-part 1: vitamins, minerals, and nutritional supplementsNoam Yarom, Allan Hovan, Paolo Bossi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 15, 2020
Systematic review of natural and miscellaneous agents, for the management of oral mucositis in cancer patients and clinical practice guidelines - part 2: honey, herbal compounds, saliva stimulants, probiotics, and miscellaneous agentsNoam Yarom, Allan Hovan, Paolo Bossi, et al.
Pageof 20